SIGA TECHNOLOGIES INC 4/A
4/A · SIGA TECHNOLOGIES INC · Filed Oct 22, 2010
Insider Transaction Report
Form 4/AAmended
MJALLI ADNAN M M
Director
Transactions
- Sale
Common Stock
2009-09-30$6.24/sh−3,851,969$24,036,287→ 20,983 total(indirect: by TransTech Pharma, Inc.) - Exercise of In-Money
Warrant (right to buy)
2009-09-30−1,845,396→ 0 total(indirect: By TransTech Pharma, Inc.)Exercise: $1.88From: 2004-01-08Exp: 2011-01-08→ Common Stock (1,845,396 underlying) - Exercise of In-Money
Common Stock, par value $0.0001 per share ("Common Stock")
2009-09-30$1.88/sh+1,845,396$3,466,392→ 4,317,618 total(indirect: by TransTech Pharma, Inc.) - Tax Payment
Common Stock
2009-09-30$7.80/sh−444,666$3,468,395→ 3,872,952 total(indirect: by TransTech Pharma, Inc.)
Footnotes (2)
- [F1]On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
- [F2]The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.